NOX2 NADPH-OXIDASE A NOVEL TARGET TO PREVENT INSULIN RESISTANCE RELATED ENDOTHELIAL CELL DYSFUNCTION

NOX2 NADPH-OXIDASE A NOVEL TARGET TO PREVENT INSULIN RESISTANCE RELATED ENDOTHELIAL CELL DYSFUNCTION

Bibliographic Details
Main Authors:	Sukumar, P, Viswambharan, H, Imrie, H, Cubbon, R, Yuldasheva, N, Gage, M, Galloway, S, Skromna, A, Smith, J, Gatenby, K, Beech, D, Wheatcroft, S, Channon, K, Shah, A, Kearney, M
Format:	Conference item
Published:	2012

Similar Items

TARGETING NOX2 NADPH OXIDASE IN INSULIN RESISTANCE RELATED ENDOTHELIAL DYSFUNCTION
by: Sukumar, P, et al.
Published: (2013)

TARGETING NOX2 NADPH OXIDASE IN INSULIN RESISTANCE RELATED ENDOTHELIAL DYSFUNCTION
by: Sukumar, P, et al.
Published: (2013)

Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.
by: Sukumar, P, et al.
Published: (2013)

Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice.
by: Imrie, H, et al.
Published: (2012)

The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium
by: Abbas, A, et al.
Published: (2011)

The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.
by: Abbas, A, et al.
Published: (2011)

Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease
by: Hayes, P, et al.
Published: (2015)

NADPH oxidase involvement in cellular integrity.
by: Macpherson, N, et al.
Published: (2008)

S-nitrosylation of NADPH oxidase regulates cell death in plant immunity
by: Yun, Byung Wook, et al.
Published: (2011)

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
by: Guzik, T, et al.
Published: (2000)

Natural bioactive compounds targeting NADPH oxidase pathway in cardiovascular diseases
by: M. Sofiullah, Siti Sarah, et al.
Published: (2023)

A genome‐wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes
by: Meng, W, et al.
Published: (2018)

NADPH-oxidase activity in peripheral blood mononuclear cells as a novel inflammatory marker in atherosclerosis
by: Antoniades, C, et al.
Published: (2010)

Relationship of NAD(P)H oxidase activity in human blood vessels to endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Modulation of atrial fibrillation susceptibility by gp91phox-containing NADPH oxidases
by: Mighiu, A
Published: (2018)

Reactive oxygen species produced by NADPH oxidase regulate plant cell growth.
by: Foreman, J, et al.
Published: (2003)

NADPH oxidase activity in internal mammary arteries predicts mortality in patients undergoing coronary bypass surgery
by: Akoumianakis, I, et al.
Published: (2018)

The Interplay Between Perivascular Adipose Tissue and the Arterial Wall Regulates NADPH-Oxidase Activity in Human Vessels
by: Margaritis, M, et al.
Published: (2013)

Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: Studies in endothelial-targeted Nox2 transgenic mice
by: Bendall, J, et al.
Published: (2006)

Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice.
by: Bendall, J, et al.
Published: (2007)

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Mechanisms of oxidative stress in human aortic abdominal aneurysms - Role of iNOS, NADPH oxidase and relationship to clinical features.
by: Guzik, B, et al.
Published: (2006)

Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors
by: Guzik, T, et al.
Published: (2000)

Vascular superoxide production in human coronary artery disease. Relationships between Nox expression and oxidase activity
by: Guzik, T, et al.
Published: (2004)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
by: Antoniades, C, et al.
Published: (2011)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
by: Guzik, T, et al.
Published: (2004)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
by: Guzik, T, et al.
Published: (2004)

Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: Studies in endothelial-targeted Nox2 transgenic mice (vol 100, pg 1016, 2007)
by: Bendall, J, et al.
Published: (2008)

Atorvastatin directly improves vascular redox state by affecting eNOS coupling and NADPH-oxidase activity in human vein grafts ex-vivo
by: Bakogiannis, C, et al.
Published: (2010)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
by: Kim, Y, et al.
Published: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
by: Kim, Y, et al.
Published: (2005)

Targeted endothelial Nox2 over-expression potentiates angiotensin ii induced aortic dissection in mice
by: Fan, L, et al.
Published: (2010)

Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
by: Alp, N, et al.
Published: (2003)

Perivascular adipose tissue supresses superoxide production in internal mammary artery grafts by regulating Rac1-mediated activation of vascular NADPH-oxidase
by: Margaritis, M, et al.
Published: (2013)

Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
by: Antoniades, C, et al.
Published: (2010)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)
by: Kim, Y, et al.
Published: (2003)

ENDOTHELIAL SPECIFIC NOX2 OVER-EXPRESSION INCREASES SUSCEPTIBILITY TO ANGIOTENSIN II INDUCED AORTIC DISSECTION
by: Fan, L, et al.
Published: (2012)

Atorvastatin rapidly improves redox state in human vein grafts ex-vivo, by directly reducing NADPH-oxidase activity and improving eNOS coupling
by: Bakogiannis, C, et al.
Published: (2010)

Mechanisms regulating myocardial redox state in chronic atrial fibrillation: the role of NADPH-oxidase and uncoupled nitric oxide synthases
by: Margaritis, M, et al.
Published: (2010)